The CDC estimates that every year in the United States, 33,700 people are diagnosed with a cancer caused by HPV infection. HPV vaccination could help prevent more than 90% of these cancers, 31,200 cases every year, from ever occurring. HPV vaccination rates in the US are low.1 In 2017, US HPV vaccination rate for 13-17 year old adolescents was reported at 48.6%.2 For Maine, the most recent data in January 2018 for boys and girls age 13-17 up-to-date on HPV vaccination is 53.7%.3 Although the vaccination numbers are slowly climbing, there is more work which must be done to increase HPV vaccination rates and awareness both in the US and in the state of Maine.


Qualidigm created and facilitated an HPV Vaccination Learning Collaborative with pediatric and primary care practices in Maine with the goal of increasing HPV vaccination rates for girls and boys, ages 11-13. The Learning Collaborative includes programs such as:

  • Monthly coaching calls accompanied by links to resources such as national webinars and patient handouts
  • In-person, peer-to-peer learning sessions to learn more about evidenced-based interventions to increase HPV vaccination rates, share best practices, and network together.
  • On-site provider and clinical staff training
  • On-site technical support for practice teams.


In the first year of the HPV Vaccination Learning Collaborative, each of the three large pediatric practices that participated had an increase of 5%, 7% and 10% respectively in their 13-year-old HPV vaccination rates with all meeting, or exceeding, the Year One project goal of 5%. All the practices implemented new, sustainable processes around HPV vaccinations and continue to increase their HPV vaccination rates.

2 Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years – United States, 2017. MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917. doi: 10.15585/mmwr.mm6733a1.